Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Hanmi
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
efinopegdutide
(HM12525A) / Merck (MSD)
Luminate
(risuteganib) / Allegro Ophthalmics
poseltinib
(HM71224) / Hanmi
belvarafenib
(RG6185) / Hanmi
HM15136
/ Hanmi
HM15912
/ Hanmi
efocipegtrutide
(HM15211) / Hanmi
efpegsomatropin
(HM10560A) / Hanmi
tivumecirnon
(FLX475) / RAPT Therap, Hanmi
LAPS-IFNα
(HM10660A) / Hanmi
fidasimtamab
(IBI315) / Hanmi, Innovent Biologics
tuspetinib
(HM43239) / Aptose Biosci
